“Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S90. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/487.